Revealed: Immunoassay in R&D Market Poised for Transformation by 2035
The Immunoassay in R&D Market is entering a transformative phase, projected to achieve an impressive valuation of USD 25.99 billion by 2035, with a notable compound annual growth rate (CAGR) of 7.63%. This expected growth trajectory signals an escalating global appetite for innovative diagnostic solutions, particularly in response to the increasing prevalence of chronic and infectious...
0 Comments 0 Shares 162 Views 0 Reviews